Osteoarthritis, Knee
Conditions
Brief summary
To study synovial membrane (SM) inflammation in suprapatellar fossa in advanced knee osteoarthritis (OA), and to correlate the pathological features with clinical findings.
Interventions
Postoperative usage of intravenous methylprednisolone
Sponsors
Study design
Eligibility
Inclusion criteria
* patients undergoing elective, unilateral, primary TKA for advanced osteoarthritis.
Exclusion criteria
\- revisions, bilateral procedures, alcohol or medical abuse, administration of any glucocorticoids during the 3 months prior to surgery, and/or a history of serious cardiac or cerebrovascular problems, severe liver or kidney failure, and/or connective tissue disease including rheumatoid arthritis, ankylosing spondylitis, and systemic lupus erythematosus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between pathological features and clinical scores | 1 day. |
| Correlation between pathological features and laboratory index | 1 day |
Countries
China